Richard E. Pratley, MD | The Becker's Healthcare Podcast features Dr. Pratley discussing the FLOW study

In this episode, Dr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute, discusses a groundbreaking study on Ozempic. Dr. Pratley shares insights from the global FLOW study, highlighting Ozempic's potential to reduce chronic kidney disease.


Recent News

6 items. To interact with these items, press Control-Option-Shift-Right Arrow.

AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training

“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...